Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
TG Therapeutics, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES
Ticker
Exchange
SIC #
Website
Latest Ticker
TGTX
Nasdaq
2836
www.tgtherapeutics.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for TG Therapeutics, Inc.
TG Therapeutics Stock Rises 7% on Strong Q4 & 2025 Preliminary Results
- Jan 14th, 2026 8:52 am
TG Therapeutics Provides Preliminary Fourth Quarter and Full Year 2025 Net Product Revenue and 2026 Revenue Guidance and Anticipated Development Milestones
- Jan 13th, 2026 2:25 pm
TG Therapeutics to Participate in the 44th Annual J.P. Morgan Healthcare Conference
- Jan 7th, 2026 5:30 am
Investing in TG Therapeutics (NASDAQ:TGTX) three years ago would have delivered you a 160% gain
- Dec 28th, 2025 6:38 am
Is the Options Market Predicting a Spike in TG Therapeutics Stock?
- Dec 19th, 2025 6:32 am
Can Clinical Progress Updates Boost TG Therapeutics' Value in 2025?
- Nov 29th, 2025 8:13 am
TG Therapeutics to Participate in the 8th Annual Evercore Healthcare Conference
- Nov 28th, 2025 5:30 am
TG Therapeutics Makes 2025 Deloitte Technology Fast 500™ List of America’s Fastest-Growing Companies
- Nov 19th, 2025 6:30 am
TG Therapeutics Crumbles After Roche Unveils Its 'Unprecedented' Test Results
- Nov 10th, 2025 2:54 pm
TG Therapeutics to Participate in the TD Cowen Immunology & Inflammation Summit
- Nov 10th, 2025 2:00 pm
TG Therapeutics (TGTX) Margin Miss Challenges Growth-Driven Profitability Narrative
- Nov 4th, 2025 9:23 am
TGTX's Q3 Earnings & Revenues Trump Estimates, 2025 View Raised
- Nov 4th, 2025 8:26 am
TG Therapeutics (TGTX): Exploring Valuation as Growth Prospects Spark Investor Interest
- Nov 4th, 2025 8:13 am
Highly Watched TG Therapeutics Smashes Profit Views — But There's A Caveat
- Nov 3rd, 2025 2:25 pm
TG Therapeutics Inc (TGTX) Q3 2025 Earnings Call Highlights: Record Revenue Surge and Strategic ...
- Nov 3rd, 2025 2:00 pm
TG Therapeutics: Q3 Earnings Snapshot
- Nov 3rd, 2025 5:09 am
TG Therapeutics Reports Third Quarter 2025 Financial Results and Raises BRIUMVI Revenue Guidance
- Nov 3rd, 2025 5:00 am
TG Therapeutics, Inc. (NASDAQ:TGTX) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?
- Oct 31st, 2025 9:01 am
TG Therapeutics to Host Conference Call on Third Quarter 2025 Financial Results and Business Update
- Oct 31st, 2025 5:30 am
Earnings Preview: Amgen (AMGN) Q3 Earnings Expected to Decline
- Oct 28th, 2025 8:00 am
Scroll